- Home
- IZM vs KALA Comparison
IZM vs KALA Comparison
Compare IZM & KALA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IZM
- KALA
- Stock Information
- Founded
- IZM 2011
- KALA 2009
- Country
- IZM China
- KALA United States
- Employees
- IZM N/A
- KALA N/A
- Industry
- IZM Consumer Electronics/Video Chains
- KALA Biotechnology: Pharmaceutical Preparations
- Sector
- IZM Consumer Discretionary
- KALA Health Care
- Exchange
- IZM Nasdaq
- KALA Nasdaq
- Market Cap
- IZM 28.7M
- KALA 26.2M
- IPO Year
- IZM 2023
- KALA 2017
- Fundamental
- Price
- IZM $2.61
- KALA $5.70
- Analyst Decision
- IZM
- KALA Strong Buy
- Analyst Count
- IZM 0
- KALA 3
- Target Price
- IZM N/A
- KALA $14.00
- AVG Volume (30 Days)
- IZM 24.4K
- KALA 71.9K
- Earning Date
- IZM 07-25-2025
- KALA 08-05-2025
- Dividend Yield
- IZM N/A
- KALA N/A
- EPS Growth
- IZM N/A
- KALA N/A
- EPS
- IZM N/A
- KALA N/A
- Revenue
- IZM $180,553,977.00
- KALA N/A
- Revenue This Year
- IZM N/A
- KALA N/A
- Revenue Next Year
- IZM N/A
- KALA N/A
- P/E Ratio
- IZM N/A
- KALA N/A
- Revenue Growth
- IZM N/A
- KALA N/A
- 52 Week Low
- IZM $1.18
- KALA $2.92
- 52 Week High
- IZM $3.19
- KALA $11.20
- Technical
- Relative Strength Index (RSI)
- IZM 56.02
- KALA 66.64
- Support Level
- IZM $2.50
- KALA $4.36
- Resistance Level
- IZM $2.74
- KALA $5.75
- Average True Range (ATR)
- IZM 0.10
- KALA 0.54
- MACD
- IZM -0.00
- KALA 0.08
- Stochastic Oscillator
- IZM 57.89
- KALA 82.44
About IZM ICZOOM Group Inc.
ICZOOM Group Inc is engaged in the sale of electronic component products to customers in China. These products are used by small and medium-sized enterprises (SMEs) in the consumer electronic industry, Internet of Things (IoT), automotive electronics, and industrial control segment. In addition to the sales of electronic component products, also provides services to customers such as temporary warehousing, logistic and shipping, and customs clearance and charges them additional service commission fees. The company earns maximum revenue from sale of electronic components.
About KALA KALA BIO Inc.
Kala Bio Inc is a biopharmaceutical company. The company is a clinical-stage biopharmaceutical company dedicated to researching, developing, and commercializing therapies for rare and severe eye diseases. KALA'smain product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.